Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: Carl R. who wrote (121)	2/2/2000 6:27:00 PM
From: Mad2	Read Replies (1) \| Respond to of 207

Carl, as your long you would be well served to give GUMM a call and ask how much ZICAM has been shipped in Jan and get their order book for Feb/March. Generally companies will provide this kind of data as it's readily available to insiders who can also act upon their knowledge of this information. I'd call, but the small caps I invest in always ask my name and if I'm a shareholder, which in this case I'm not (but am a investor). Hate to lie (and they have shareholder lists anyway)......except when I know I can't get caught. If they don't give it to you, I'd ask if it is available to insiders who can act upon that information to buy or sell stock. Mad2 I'd predict that if Zicam revenues are soft for the 1st qtr, say less than 4 mil resulting in neg. net income. GUMM will be be back to the 10-15 range easy. Because the Zicam story will still have some air in it (meaning growth potential that is left to the imagination of the marketplace) I don't think it has much of a chance to get below 10 for long however much of that could be dependant on the mood of the market, which as you know can change. Right now a lot will be dependant on 1st qtr revenue....information available to you. All IMHO